HEALTH

New PowerBar High Intensity rolls into retail

BY Michael Johnsen

FLORHAM PARK, N.J. Nestle Performance Nutrition on Tuesday announced its entry into the sport dietary supplement category with the launch of a line of dietary supplements under the brand PowerBar Elite Series High Intensity. Formulated with sustained-release beta alanine for endurance, the line will carry the NSF Certified for Sport certification for sports nutrition products.

 

"With studies published in the last couple of years, the amino acid beta alanine appears to be joining a small list of nutritional ingredients with good scientific support for helping athletes perform at their best," stated Eric Zaltas, business development director for Nestle Performance Nutrition. "Providing the sustained-release form of beta alanine and gaining NSF certification were important considerations for us as we move into the sports dietary supplement category."

 

 

Studies suggest beta alanine supplementation can enhance performance in efforts lasting between one minute and 10 minutes, such as cycling over the top of a hill, high-intensity interval training or in sports events falling within this range.

 

Each PowerBar High Intensity two-tablet serving provides 1.6 g of beta alanine. For optimum results, athletes should take two tablets twice daily for the first four weeks and two tablets once per day thereafter. With this regimen, athletes typically see results in four to eight weeks.

 

The supplement started shipping in September through sports specialty retailers and PowerBar.com for a suggested retail price of $39.99 per 56-serving bottle.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

NACDS issues statement on CMS’ withdrawal of AMP provisions

BY Allison Cerra

ALEXANDRIA, Va. The National Association of Chain Drug Stores commended the Centers for Medicare and Medicaid Services on Tuesday after the agency proposed a rule that would withdraw two provisions related to pharmacy Medicaid reimbursement.

In a letter to CMS, NACDS said that it believed the average manufacturer price final rule was "fundamentally flawed, and implemented the Medicaid pharmacy reimbursement provisions of the Deficit Reduction Act of 2005 in a manner that was inconsistent with congressional intent," the letter stated. "Rather than continuing efforts to implement the flawed AMP final rule, we applaud the agency for moving forward with withdrawing the provisions of the AMP final rule, as well as the multiple-source drug rule."

Federal law defines AMP as “with respect to a covered outpatient drug of a manufacturer for a rebate period, the average price paid to the manufacturer for the drug in the United States by wholesalers for drugs distributed to retail community pharmacies and retail community pharmacies that purchase drugs directly from the manufacturer.” The current AMP policy almost could cause retail pharmacies to lose money on nearly every Medicaid generic prescription they dispense.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

PSE sales tracking system nabs meth ring

BY Michael Johnsen

DALLAS Arkansas state police apprehended and arrested a methamphetamine ring, which had been attempting to acquire large quantities of the precursor ingredient pseudoephedrine at retail pharmacy. The police were tipped off thanks to information provided by LeadsOnLabs, an online system that helps track the illegal sale of PSE, the company announced Monday.

“Breaking up this meth ring was a big step in the fight against meth in the state of Arkansas,” stated Investigator Chris Anderson of the Arkansas state police. In this particular case, some of the individuals already had reached their legal monthly sales limit and were attempting to purchase more pills. The LeadsOnLabs system blocked a total of 43 transactions of the 235 that were attempted by this group.  Because LeadsOnLabs is an online logbook and provides real-time alerts, pharmacies across the state were made aware of this group and immediately were able to deny the sale of additional pills to these individuals.

“We commend the mighty efforts of the Arkansas state police, as well as various local law enforcement agencies, and the work they do to combat meth abuse in their state,” stated Dave Finley, president and CEO of LeadsOnLabs. “We are proud to be able to help them identify individuals and groups of meth makers. Through our partnership we hope to help them win the war against methamphetamines in the state of Arkansas.”

Arkansas instituted the LeadsOnLabs system statewide in an attempt to eradicate meth abuse in the state in 2008, under the direction of Attorney General Dustin McDaniel. The system has been credited with helping law enforcement bust meth labs and track down meth abusers across the state.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES